B, C., TT, D., J, Y., T, L., D, C., KE, D., . . . AG, R. (2024). AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes. Gene therapy, 31(3-4), 175. https://doi.org/10.1038/s41434-023-00436-8
Chicago Style (17th ed.) CitationB, Chaqour, et al. "AAV2 Vector Optimization for Retinal Ganglion Cell-targeted Delivery of Therapeutic Genes." Gene Therapy 31, no. 3-4 (2024): 175. https://doi.org/10.1038/s41434-023-00436-8.
MLA (9th ed.) CitationB, Chaqour, et al. "AAV2 Vector Optimization for Retinal Ganglion Cell-targeted Delivery of Therapeutic Genes." Gene Therapy, vol. 31, no. 3-4, 2024, p. 175, https://doi.org/10.1038/s41434-023-00436-8.
Warning: These citations may not always be 100% accurate.